At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect and Contribution of a Perioperative Ketamine Infusion in an Established Enhanced Recovery Pathway
In Brief
A Phase 4 clinical trial evaluating Ketamine and Placebo for Opioid Use and 4 related conditions. Completed, enrolled 1,570 participants across 1 site.
Detailed Summary
In order to effectively treat surgical pain with the least amount of opioids required, a multi-modal approach must include medications with different mechanisms of actions at alternative receptors. In light of the opioid epidemic, medical providers at Vanderbilt University Medical Center (VUMC) are strategically combining these medications in a bundled pain-regimen after surgery. These regimens have been shown to decrease opioid consumption, improve surgical outcomes, and reduce hospital stays, thus coining the term 'enhanced recovery pathway'. The combination of these medications has an indisputable synergistic effect. However, it is unknown how each medication contributes individually to the overall efficacy of the pathway. This study will examine the effects of ketamine, within the constructs of a multimodal pain regimen, on a) length of stay, b) opioid consumption, and c) surgical outcomes after major abdominal surgery.
Study Details
Timeline
Interventions
Participants in the ketamine arm will receive intraoperative and postoperative ketamine.
Participants in the placebo arm will receive intraoperative and postoperative saline.